Groupe Siparex

Siparex is a private equity investment group based in Lyon, France, founded in 1977. It focuses on investing in start-ups and mid-market companies across various sectors, including software, manufacturing, e-commerce, life sciences, and healthcare services, primarily in the United States and Western Europe. Over its 30-year history, Siparex has grown to become one of the independent leaders in the private equity space, having listed shares of its original company on the stock market and expanded internationally. The firm manages several funds, including those dedicated to buyouts and venture capital, with investments typically ranging from EUR 2.5 million to EUR 10 million in companies with revenues between EUR 15 million and EUR 200 million. Siparex aims to support the development of its portfolio companies through strategic investments and operational guidance.

Pierre Bordeaux Montrieux

Managing Partner, Midmarket Financing

Denis Rodarie

Managing Partner

Past deals in Lyon

Vitacuire

Private Equity Round in 2018
Vitacuire is a family-owned business specializing in frozen aperitif pastries and private label products. Founded in 1952 by restaurant owners Ginette and Emile Krief in Lyon, the company initially focused on delivering frozen puff pastry. Remaining independent and family-run, it is currently managed by Jean-Yves Krief and his sisters. Vitacuire is recognized for its expertise in puff pastry, offering a variety of products such as cocktail bites, individual pastries, and larger shareable options. Since the introduction of the third generation in 2010, the company has continued to innovate, expanding its offerings to include microwavable cocktail bites and gourmet brioche pastries, catering to a diverse clientele and preserving the nutritional qualities of its food products.

Potager City

Private Equity Round in 2017
Potager City is a retail company based in Lyon, France, that specializes in delivering fresh fruit and vegetables. Established in 2007, it operates as a subsidiary of Carrefour SA. The company focuses on providing baskets of seasonal produce sourced directly from local farmers, ensuring that customers receive fresh items promptly through a network of dedicated delivery points. Potager City is committed to facilitating a just-in-time delivery model, enhancing the accessibility of high-quality, locally sourced fruits and vegetables to consumers at their doorstep.

Groupe CARSO

Private Equity Round in 2016
Groupe CARSO is a specialized provider of environmental and agrifood analytical services, established in 1992 through a partnership between Neptune Technologies and the CNRS. Initially focused on analyzing dioxins using high-resolution mass spectrometry, the company expanded its capabilities by acquiring water and asbestos analysis operations from the Institut Pasteur in Lyon in 1997. Throughout the 2000s, CARSO enhanced its analytical expertise through strategic acquisitions of various laboratories, including those specializing in radioactivity and ecotoxicology. The company offers a comprehensive suite of services, including bioassays that utilize non-invasive pollutant shrimp to assess chemical contamination and toxicity in water and aquatic environments. This diverse range of analytical services positions Groupe CARSO as a key player in environmental monitoring and assessment.

Calixar

Series B in 2015
Calixar SAS is a biotechnology company based in Lyon, France, specializing in the deorphanization, identification, and isolation of native integral membrane proteins, which are crucial for therapeutic targets. The company offers a range of services, including the production, extraction, purification, stabilization, and crystallization of membrane proteins, such as GPCRs, ion channels, and transporters. Utilizing patented technology, Calixar ensures that these proteins remain in their complete native form, enhancing their stability in solution. Its services cater to pharmaceutical industries, biotechnology firms, and academic institutions involved in drug discovery, vaccine development, and antibody research. Founded in 2011, Calixar aims to facilitate the development of conformational antibodies and new vaccines, supporting advancements in therapeutic applications and structural biology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.